Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine

被引:18
作者
Angom, Ramcharan Singh [1 ]
Nakka, Naga Malleswara Rao [1 ]
机构
[1] Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA
关键词
cardiovascular disease; metabolic disease; transgenesis; zebrafish; gene editing; CRISPR; TALEN; PANCREATIC BETA-CELLS; WHITE ADIPOSE-TISSUE; FATTY LIVER-DISEASE; DILATED CARDIOMYOPATHY; DANIO-RERIO; CARDIAC CONTRACTILITY; INSULIN-RESISTANCE; MUSCULAR-DYSTROPHY; HEART REGENERATION; GENETIC-ANALYSIS;
D O I
10.3390/biomedicines12030693
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The zebrafish (Danio rerio) has emerged as an appreciated and versatile model organism for studying cardiovascular and metabolic diseases, offering unique advantages for both basic research and drug discovery. The genetic conservation between zebrafish and humans and their high fecundity and transparent embryos allow for efficient large-scale genetic and drug-oriented screening studies. Zebrafish possess a simplified cardiovascular system that shares similarities with mammals, making them particularly suitable for modeling various aspects of heart development, function, and disease. The transparency of zebrafish embryos enables the real-time visualization of cardiovascular dynamics, offering insights into early embryonic events and facilitating the study of heart-related anomalies. In metabolic research, zebrafish provide a cost-effective platform for modeling obesity, type 2 diabetes, hyperlipidemia, and other metabolic disorders. Their high reproductive rate allows for the generation of large cohorts for robust statistical analyses, while advanced genetic tools, such as CRISPR/Cas9, enable precise gene editing with which to model specific genetic mutations associated with human diseases. Zebrafish metabolic models have been instrumental in elucidating the molecular mechanisms underlying metabolic diseases, studying the effects of environmental factors, and identifying potential therapeutic targets. Additionally, the permeability of zebrafish embryos to small molecules facilitates drug discovery and screening, offering a rapid and economical approach to identifying compounds with therapeutic potential. In conclusion, zebrafish cardiovascular and metabolic disease models continue to contribute significantly to our perception of disease pathogenesis, providing a platform for translational research and developing novel therapeutic interventions. The versatility, scalability, and genetic manipulability of zebrafish position them as an invaluable asset in unraveling the complexities of cardiovascular and metabolic diseases. This review presents an overview of the zebrafish model's key features and contributions to investigating cardiovascular and metabolic disorders. We discuss the benefits and drawbacks of using zebrafish models to study human disease and the critical findings revealed by the progress in this endeavor to date.
引用
收藏
页数:27
相关论文
共 203 条
[1]   Adenosine Signaling Promotes Regeneration of Pancreatic β Cells In Vivo [J].
Andersson, Olov ;
Adams, Bruce A. ;
Yoo, Daniel ;
Ellis, Gregory C. ;
Gut, Philipp ;
Anderson, Ryan M. ;
German, Michael S. ;
Stainier, Didier Y. R. .
CELL METABOLISM, 2012, 15 (06) :885-894
[2]   Forward genetic screen using a gene-breaking trap approach identifies a novel role of grin2bb-associated RNA transcript (grin2bbART) in zebrafish heart function [J].
Angom, Ramcharan Singh ;
Joshi, Adita ;
Patowary, Ashok ;
Sivadas, Ambily ;
Ramasamy, Soundhar ;
Shamsudheen, K. V. ;
Kaushik, Kriti ;
Sabharwal, Ankit ;
Lalwani, Mukesh Kumar ;
Subburaj, K. ;
Singh, Naresh ;
Scaria, Vinod ;
Sivasubbu, Sridhar .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
[3]   The expanding role of fish models in understanding non-alcoholic fatty liver disease [J].
Asaoka, Yoichi ;
Terai, Shuji ;
Sakaida, Isao ;
Nishina, Hiroshi .
DISEASE MODELS & MECHANISMS, 2013, 6 (04) :905-914
[4]   Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy [J].
Asimaki, Angeliki ;
Kapoor, Sudhir ;
Plovie, Eva ;
Arndt, Anne Karin ;
Adams, Edward ;
Liu, ZhenZhen ;
James, Cynthia A. ;
Judge, Daniel P. ;
Calkins, Hugh ;
Churko, Jared ;
Wu, Joseph C. ;
MacRae, Calum A. ;
Kleber, Andre G. ;
Saffitz, Jeffrey E. .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (240)
[5]   Adipocyte Inflammation Is Essential for Healthy Adipose Tissue Expansion and Remodeling [J].
Asterholm, Ingrid Wernstedt ;
Tao, Caroline ;
Morley, Thomas S. ;
Wang, Qiong A. ;
Delgado-Lopez, Fernando ;
Wang, Zhao V. ;
Scherer, Philipp E. .
CELL METABOLISM, 2014, 20 (01) :103-118
[6]   Defective ''pacemaker'' current (I-h) in a zebrafish mutant with a slow heart rate [J].
Baker, K ;
Warren, KS ;
Yellen, G ;
Fishman, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4554-4559
[8]   The syntenic relationship of the zebrafish and human genomes [J].
Barbazuk, WB ;
Korf, I ;
Kadavi, C ;
Heyen, J ;
Tate, S ;
Wun, E ;
Bedell, JA ;
McPherson, JD ;
Johnson, SL .
GENOME RESEARCH, 2000, 10 (09) :1351-1358
[9]  
Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO
[10]  
2-#